购物车
全部删除
您的购物车当前为空
Type II TRK inhibitor 2 (compound 40l) 是一种选择性的 II 型TRK抑制剂,表现出良好的血浆稳定性和中等程度的肝微粒体稳定性。它显著抑制 Km-12、Ba/F3-TRKAG595R 以及 Ba/F3-TRKAG667C 细胞的增殖 (IC50: 4.1 nM,41.5 nM,1.4 nM)。Type II TRK inhibitor 2 可用于研究 NTRK 融合癌症。
Type II TRK inhibitor 2 (compound 40l) 是一种选择性的 II 型TRK抑制剂,表现出良好的血浆稳定性和中等程度的肝微粒体稳定性。它显著抑制 Km-12、Ba/F3-TRKAG595R 以及 Ba/F3-TRKAG667C 细胞的增殖 (IC50: 4.1 nM,41.5 nM,1.4 nM)。Type II TRK inhibitor 2 可用于研究 NTRK 融合癌症。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 10 mg | 待询 | 待询 | |
| 50 mg | 待询 | 待询 |
Type II TRK inhibitor 2 相关产品
| 产品描述 | Type II TRK inhibitor 2 (compound 40l) is a selective Type II TRK inhibitor characterized by plasma stability and moderate liver microsome stability. It significantly impedes the proliferation of Km-12, Ba/F3-TRKAG595R, and Ba/F3-TRKAG667C cells with IC50 values of 4.1 nM, 41.5 nM, and 1.4 nM, respectively. Type II TRK inhibitor 2 is applicable for research into NTRK fusion cancers. |
| 分子式 | C30H27F2N9O |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容